Showing results (151-160 of 428) with videos related to
Sort By:
Pageof 43
Journal of Nephrology|June 13, 2022
Patient perspectives on chronic kidney disease and decision-making about treatment. Discourse of participants in the French CKD-REIN cohort studyLucile Montalescot, Géraldine Dorard, Elodie Speyer, et al.Clinical Transplantation|December 28, 2020
Comparison of two strategies based on mammalian target of rapamycin inhibitors in secondary prevention of non-melanoma skin cancer after kidney transplantation, a pilot studyJulie Préterre, Jonathan Visentin, Morgane Saint Cricq, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 20, 2018
The disappointing contribution of anti-human leukocyte antigen donor-specific antibodies characteristics for predicting allograft lossMaxime Courant, Jonathan Visentin, Gabriel Linares, et al.Transplant International : Official Journal of the European Society for Organ Transplantation|July 31, 2025
Effector-Memory γδ T Lymphocytes Predict CMV Disease After the Withdrawal of Prophylaxis in Kidney Transplant RecipientsYoann Abadie, Jonathan Visentin, Elodie Wojciechowski, et al.Journal of Clinical Microbiology|December 7, 2007
Prediction of cytomegalovirus (CMV) plasma load from evaluation of CMV whole-blood load in samples from renal transplant recipientsIsabelle Garrigue, Adélaïde Doussau, Julien Asselineau, et al.Transplantation|April 6, 2011
Mycophenolate mofetil initiation in renal transplant patients at different times posttransplantation: the TranCept Switch studyHerwig-Ulf Meier-Kriesche, Pierre Merville, Helio Tedesco-Silva, et al.Blood|June 10, 2008
Long-term expansion of effector/memory Vdelta2-gammadelta T cells is a specific blood signature of CMV infectionVincent Pitard, David Roumanes, Xavier Lafarge, et al.AJR. American Journal of Roentgenology|March 26, 2013
Combined late gadolinium-enhanced and double-echo chemical-shift MRI help to differentiate renal oncocytomas with high central T2 signal intensity from renal cell carcinomasFrançois Cornelis, Anne-Sophie Lasserre, Thomas Tourdias, et al.Diagnostic and Interventional Imaging|July 13, 2023
What is the benefit of gadolinium-chelate injection for the diagnosis of local recurrence of clear cell renal cell carcinoma after percutaneous thermal ablation with MRI?Julien Gay Depassier, Amandine Crombé, Eva Jambon, et al.Journal of Personalized Medicine|January 22, 2024
Clinical, Technical, and MRI Features Associated with Patients' Outcome at 3 Months and 2 Years following Prostate Artery Embolization: Is There an Added Value of Radiomics?Antoine Martin, Clément Marcelin, François Petitpierre, et al.Pageof 43